[關(guān)鍵詞]
[摘要]
目的 探討新癀片中的中藥組分對化學(xué)藥成分吲哚美辛的減毒作用。方法 采用急性毒性實驗。給ICR小鼠分別ig不同劑量的新癀片、化學(xué)藥成分吲哚美辛,記錄各組小鼠的死亡數(shù)、毒性癥狀,用Bliss法分別計算LD50。同時另設(shè)新癀片中藥組分組,確定其最大給藥量,并觀察毒性反應(yīng)。結(jié)果 新癀片中藥組分對小鼠的1日最大給藥量為18.2 g/kg。吲哚美辛的LD50為18.31 mg/kg,新癀片的LD50為1 217.83 mg/kg,由于吲哚美辛在新癀片中的質(zhì)量分?jǐn)?shù)為2.478%,因此折算成新癀片中吲哚美辛的LD50為30.16 mg/kg。結(jié)論 新癀片中中藥組分對吲哚美辛具有減毒作用。
[Key word]
[Abstract]
Objective To study the attenuation effect of Chinese medicinal components in Xinhuang Tablets on indomethacin.Methods Various doses of Xinhuang Tablets and indomethacin were given to ICR mice by ig administrationClinical signs and death were recorded LD50 was computed by Bliss method Meanwhile the maximal administration dose of Chinese medicinal components in Xinhuang Tablets was included,and their acute toxic reactions were observed. Results There were no toxic effects observed when a 18.2 g/kg dose of Chinese medicinal components in Xinhuang Tablets (the maximal acceptable dose) was given to mice. The LD50 of indomethacin in mice was 18.31 mg/kg. The LD50 of Xinhuang Tablets in mice was 1 217.83 mg/kg. As the content of indomethacin in Xinhuang Tablets was 2.478%,the equivalent LD50 of indomethacin in mice was 30.16 mg/kg.Conclusion Chinese medicinal components in Xinhuang Tablets can reduce the toxicity of indomethacin.
[中圖分類號]
[基金項目]
國家科技支撐計劃地方重大專項(2007BAQ00162)